Zacks Small Cap Forecasts Increased Earnings for Spectral AI

Key Points

• Analysts at Zacks Small Cap have raised their Q3 2025 earnings per share estimate for Spectral AI to ($0.08), improving from a previous estimate of ($0.09).
• Wall Street Zen has downgraded Spectral AI's rating from "hold" to "strong sell", indicating a lack of confidence in the company's future performance.
• Institutional investors now hold 67.08% of Spectral AI's stock, with notable purchases made by Geode Capital Management and Renaissance Technologies in recent quarters.

Spectral AI, Inc. (NASDAQ:MDAI - Free Report) - Stock analysts at Zacks Small Cap boosted their Q3 2025 earnings estimates for shares of Spectral AI in a report released on Thursday, August 14th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will post earnings of ($0.08) per share for the quarter, up from their previous forecast of ($0.09). The consensus estimate for Spectral AI's current full-year earnings is ($0.48) per share. Zacks Small Cap also issued estimates for Spectral AI's Q4 2025 earnings at ($0.08) EPS.

Separately, Wall Street Zen downgraded shares of Spectral AI from a "hold" rating to a "strong sell" rating in a report on Saturday, August 16th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Spectral AI currently has a consensus rating of "Buy" and an average target price of $3.50.

Spectral AI Stock Performance

Shares of MDAI stock traded up $0.07 during midday trading on Monday, hitting $2.09. 267,721 shares of the company were exchanged, compared to its average volume of 382,353. The firm has a market capitalization of $52.92 million, a P/E ratio of -3.03 and a beta of 0.90. Spectral AI has a 52 week low of $0.82 and a 52 week high of $3.25. The firm's 50 day moving average price is $2.42 and its two-hundred day moving average price is $1.84.

Spectral AI (NASDAQ:MDAI - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.03). The firm had revenue of $5.07 million for the quarter, compared to the consensus estimate of $5.44 million. Spectral AI has set its FY 2025 guidance at EPS.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Northern Trust Corp bought a new position in shares of Spectral AI in the fourth quarter valued at $44,000. Jane Street Group LLC purchased a new stake in Spectral AI during the second quarter worth about $74,000. Marshall Wace LLP bought a new position in Spectral AI during the second quarter worth about $104,000. DNB Asset Management AS bought a new position in Spectral AI during the second quarter worth about $107,000. Finally, XTX Topco Ltd bought a new position in Spectral AI during the second quarter worth about $123,000. 67.08% of the stock is owned by institutional investors.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.